Filing Flows › NovoCure (NVCR) › Free cash flow
NovoCure (NVCR) free cash flow by quarter
NovoCure's free cash flow was $15.7M in Q3 2026 (third quarter 2026), up 13-fold from Q2 2026. Over the last 3 quarters it ranged from $1.2M (Q2 2026) to $15.7M (Q3 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $15.7M | 13× | +6% |
| Q2 2026 | $1.2M | -92% | — |
| Q3 2025 | $14.9M | — | — |
Q3 2026 at a glance
NovoCure, Q3 2026: revenue $193M (+16% year over year), operating margin -3.2%, net loss $10.4M, operating cash flow $22.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is NovoCure's free cash flow?
NovoCure's free cash flow was $15.7M in Q3 2026 (third quarter 2026), up 13-fold from Q2 2026.
How has NovoCure's free cash flow changed?
Over the last 3 quarters it ranged from $1.2M (Q2 2026) to $15.7M (Q3 2026).